The fasting insulin test is a blood test that measures the level of insulin in your blood after you have fasted (not eaten or drunk anything except water) for at least 8 hours. Insulin is a hormone produced by the pancreas that helps regulate blood sugar levels. The fasting insulin test is often used to help diagnose conditions such as insulin resistance, prediabetes, and type 2 diabetes. It may also be ordered to monitor the effectiveness of treatment for these conditions. The test is usually done in the morning, after an overnight fast. The test results will be reported in units of insulin per liter of blood (U/L). It is important to note that the interpretation of a fasting insulin test may vary depending on the individual's medical history and other factors. A healthcare provider should be consulted to interpret the test results correctly.

The Urinalysis test panel screens for a variety of conditions including urinary tract infections ( UTI ), urinary bladder disease, kidney disease and diabetes. Tests included: Color, Appearance, Specific gravity, pH, Protein, Glucose, Occult blood, Ketones, Leukocyte esterase, Nitrite, Bilirubin, Urobilinogen, and Microscopic examination of urine sediment

Vitamin B-12 is an essential vitamin. Low blood levels of B12 can cause: Anemia and pernicious anemia, loss of balance , numbness or tingling in the arms and legs, and weakness

Cortisol (hydrocortisone) is the most prominent glucocorticosteroid, and it is essential for the maintenance of several body functions. The most important physiological effects of cortisol are that it raises blood sugar levels (enhances gluconeogenesis, or breaks down glucose) and lowers inflammation and the immune system.

Lipid Panel: Evaluates the risk for developing atherosclerosis (arterial plaque) and coronary heart disease. This test includes: Total Cholesterol, Triglycerides ,HDL Cholesterol, LDL Cholesterol, Total Cholesterol/HDL Ratio. FASTING REQUIRED.

The Cardio IQ® Insulin Resistance Score (IR), which uses fasting insulin and C-peptide measurements to estimate a person's likelihood of having insulin resistance. It eliminates the need for multiple samples and reduces the chance of errors that can occur with some other tests.

Having a high score (indicating a greater probability of insulin resistance) was linked to an increased risk of developing type 2 diabetes, even after accounting for other risk factors. 

An IR score of <33 suggests that an individual has normal insulin sensitivity.
A score of 33 to 66 suggests that an individual has >4-fold greater odds of having IR compared with an individual with a score <33 .
A score >66 suggests that an individual has >15-fold greater odds of having IR compared to an individual with a score

Fasting Required for 10-12 hours. Water only.

ApoB Blood Test has been reported to be a powerful indicator of Coronary Artery Disease (CAD). In some patients with CAD, APO B is elevated even in the presence of normal LDL cholesterol. Instead of non-HDL-C levels, ApoB levels may be used to check how well lipid treatment is working. Non-HDL-C is the total cholesterol concentration minus the amount of HDL. A healthcare practitioner may order both an lipoprotein a (associated with high-density lipoprotein (HDL), the "good" cholesterol) and an apo B to determine an apo B/apo A-I ratio. This ratio is sometimes used as an alternative to a total cholesterol/HDL ratio to evaluate risk for developing CVD.

Elevated levels of homocysteine in the blood, known as hyperhomocysteinemia, have been linked to an increased risk of cardiovascular disease, including heart attack and stroke. High homocysteine levels may also be associated with an increased risk of certain other health conditions, such as osteoporosis and pregnancy complications.

This high sensitivity CRP test is used along other blood markers to assess a patient's potential risk for cardiovascular disease. To illustrate the difference between CRP and hs-CRP, traditional testing measures CRP (quantitative) within the range of 10 to 1,000 mg/L, whereas hs-CRP values range from 0.5 to 10 mg/L. In simpler terms, hs-CRP measures trace amounts of CRP in the blood. Hs-CRP is the analyte of choice for cardiovascular risk assessment

Insulin-like Growth Factor 1, also known as IGF-1, is used as a biomarker for blood levels of human growth hormone. It is a hormone produced by the liver and other tissues which affects growth-promoting activities and glucose metabolism. The blood level of IGF-1 appears to fluctuate over 24 hours and is found to be related to growth hormone secretion.

This test measures levels of drenocorticotropic hormone (ACTH), which is also called adrenocorticotropin and corticotropin, a hormone made in the anterior pituitary gland that tells the adrenal glands to release cortisol, DHEA, and aldosterone. The ACTH plasma test quantifies the blood's level of ACTH. A patient's blood is drawn for the test and then sent to a lab for examination. The test findings enable the diagnosis of ailments such as Addison's disease, Cushing's syndrome, and adrenal tumors

Quest Diagnostics test code 17911 is for a DNA mutation analysis of Methylenetetrahydrofolate Reductase (MTHFR). The test determines if a patient has one, two, or no copies of either of the two mutations in the MTHFR gene, C677T and A1298C.

Changes in the methylenetetrahydrofolate reductase gene can lead to certain health conditions. One of them is hyperhomocysteinemia (high blood levels of homocysteine), which is a risk factor for cerebrovascular disease, cerebral vein thrombosis, coronary artery disease, myocardial infarction, and venous thrombosis. At least 40 mutations in the MTHFR gene have been identified in people with homocystinuria, a disorder in which the body is unable to process certain amino acids properly.